Glaukos (GKOS) EBT (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.38% |
| Dec 31, 2025 | 461.44% |
| Sep 30, 2025 | 17.58% |
| Jun 30, 2025 | -8.92% |
| Mar 31, 2025 | -115.61% |
| Dec 31, 2024 | 637.56% |
| Sep 30, 2024 | 57.72% |
| Jun 30, 2024 | -24.10% |
| Mar 31, 2024 | -139.87% |
| Dec 31, 2023 | 433.76% |
| Sep 30, 2023 | 6.08% |
| Jun 30, 2023 | 5.40% |
| Mar 31, 2023 | -148.79% |
| Dec 31, 2022 | 356.70% |
| Sep 30, 2022 | 40.12% |
| Jun 30, 2022 | -900.30% |
| Mar 31, 2022 | 123.43% |
| Dec 31, 2021 | -478.39% |
| Sep 30, 2021 | 137.24% |
| Jun 30, 2021 | -6.70% |
| Mar 31, 2021 | -16.55% |
| Dec 31, 2020 | 16.51% |
| Sep 30, 2020 | 64.81% |
| Jun 30, 2020 | 13.26% |
| Mar 31, 2020 | -84.38% |
| Dec 31, 2019 | -121.96% |
| Sep 30, 2019 | -113.55% |
| Jun 30, 2019 | -411.23% |
| Mar 31, 2019 | -152.84% |
| Dec 31, 2018 | 135.07% |
| Sep 30, 2018 | -22.22% |
| Jun 30, 2018 | -99.08% |
| Mar 31, 2018 | -379.26% |
| Dec 31, 2017 | -29.68% |
| Sep 30, 2017 | 142.03% |
| Jun 30, 2017 | -451.45% |
| Mar 31, 2017 | -87.86% |
| Dec 31, 2016 | 491.69% |
| Sep 30, 2016 | -44.30% |
| Jun 30, 2016 | 159.98% |
| Mar 31, 2016 | -97.40% |
| Dec 31, 2015 | 1,776.86% |
| Sep 30, 2015 | 93.67% |
| Jun 30, 2015 | -2,123.80% |
| Mar 31, 2015 | 66.21% |
| Dec 31, 2014 | -120.09% |
| Sep 30, 2014 | 21.17% |
| Jun 30, 2014 | 38.05% |